arrow-left-endarrow-right-end

News & Updates

The Latest on Internet Pharmacies, Supplements, Designer Drugs,
and Other High-Risk Merchants

Filter By:

Why Are Supplement Ingredient Names So Confusing?

Have you ever heard of 1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol or 4-[2-(dimethylamino)ethyl]phenol? Probably not. How about higenamine or hordenine? That may be more likely, but did you know that 1-(4-hydroxybenzyl)-1,2,3,4-tetrahydroisoquinoline-6,7-diol and higenamine are actually the same ingredient? The same is true for 4-[2-(dimethylamino)ethyl]phenol and hordenine.  Ingredient names can be confusing because manufacturers don’t always follow guidelines set by the…

Continue Reading ›

New Supplement Website Certification Program Helps Sellers Reduce Advertising and E-commerce Disruptions

We’re pleased to announce today LegitScript’s newest certification program — one to certify the websites of dietary supplement sellers as a way for them to demonstrate credibility and regulatory compliance. Now, all US supplement manufacturers, resellers, and affiliates can apply through LegitScript to certify that their websites have been reviewed for problematic products, ingredients, and…

Continue Reading ›

LegitScript Named an Inc. 5000 Company for 2019

We’re pleased to announce that LegitScript has been named an Inc. 5000 company by Inc. magazine for 2019. This designation establishes LegitScript as one of America’s most successful businesses. The 2019 Inc. 5000 list is a compilation of this year’s fastest-growing privately held companies in the US. Companies are ranked according to percentage revenue growth…

Continue Reading ›

“Alzheimer’s” on Track to Win LegitScript’s Infamous Yellow Flag Award for 2019

“Alzheimer’s” and related disease terms are on track to be this year’s top impermissible supplement marketing claim, which would earn it the LegitScript Yellow Flag Award for 2019. With four months still left in the year, will “Alzheimer’s” beat last year’s top impermissible claim — “inflammation” — or 2017’s winner, “cancer”? Only time and shady…

Continue Reading ›

More Than Half of Online Drug Sellers Are Operating Illegally with Respect to Chinese Law and Regulation, New LegitScript and ASOP Global Study Finds

A new report on the Chinese internet pharmacy market by ASOP Global and LegitScript finds that most online drug sellers are operating illegally, and that a noteworthy percentage are illegally offering prescription drugs or controlled substances. The report, titled “The Chinese Internet Pharmacy Market Threat Assessment,” includes new information about the situation in China related…

Continue Reading ›

Addiction Treatment Certification One Year In: Why It’s More Important Than Ever

LegitScript recently celebrated the one-year anniversary of the launch of our Drug and Alcohol Addiction Treatment Certification program, and our certification team reflected on both the  lessons and accomplishments of this monumental program. As a member of the customer success team, I see firsthand the value our customers get out of certification. But more importantly,…

Continue Reading ›

Seizures Related to Vaping Highlight Risk of E-cigarette Merchants

The FDA said this week that it is investigating 127 incidents of people suffering from seizures after vaping. The news highlights the elevated risk e-cigarette products pose for legal violations, and why payment service providers should know about the many types of products and parts related to vaping to better monitor their portfolios.  The FDA’s…

Continue Reading ›

CBD Confusion in Iowa Highlights the Difficulty in Navigating Local CBD Laws

The Iowa Attorney General’s Office recently reminded Iowans that cannabidiol (CBD) is still considered a controlled substance in the state despite the newly passed Iowa Hemp Act, which legalized the production of hemp containing less than 0.3% THC. The confusion has resulted in enforcement efforts to stop its sale, and it illustrates a larger legal…

Continue Reading ›

The Top Marketing Claims CBD Merchants and Manufacturers Should Avoid

One of the aspects of cannabidiol (CBD) sales that can attract regulatory scrutiny is the way in which merchants market their CBD products. In the past five years, the FDA has sent many warning letters to manufacturers and merchants of CBD products for claims that their products can prevent, cure, mitigate, or treat diseases. No…

Continue Reading ›

LegitScript Announces New CBD Certification Program

We’re happy to announce a new certification program for legally compliant CBD products and websites. Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws. LegitScript is the global leader in merchant and…

Continue Reading ›

[Webinar]
[Webinar]